The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
Open accessAbstract
Tuberculosis is a serious global health problem caused by the bacterium Mycobacterium tuberculosis. There is an urgent need for discovery and development of new treatments, but this can only be accomplished through rapid and reproducible M. tuberculosis assays designed to identify potent inhibitors. We developed an automated 96-well assay utilizing a recombinant strain of M. tuberculosis expressing a far-red fluorescent reporter to determine the activity of novel compounds; this allowed us to measure growth by monitoring both optical density and fluorescence. We determined that optical density and fluorescence were correlated with cell number during logarithmic phase growth. Fluorescence was stably maintained without antibiotic selection over 5 days, during which time cells remained actively growing. We optimized parameters for the assay, with the final format being 5 days' growth in 96-well plates in the presence of 2% w/v DMSO. We confirmed reproducibility using rifampicin and other antibiotics. The dual detection method allows for a reproducible calculation of the minimum inhibitory concentration (MIC), at the same time detecting artefacts such as fluorescence quenching or compound precipitation. We used our assay to confirm anti-tubercular activity and establish the structure activity relationship (SAR) around the imidazo[1,2-a]pyridine-3-carboxamides, a promising series of M. tuberculosis inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Collins, L., & Franzblau, S. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1004 · Cited by 1,599
Andreu, N., Fletcher, T., Krishnan, N., Wiles, S., & Robertson, B. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr472 · Cited by 115 · cited 1×
“Use of the lux operon abolishes the need for an exogenous substrate, but there are no data on the reproducibility or robustness of the assay [18] [21].”
Background
Cited by
Recent advances of pyrazole-containing derivatives as anti-tubercular agents
Xu, Z., Gao, C., Ren, Q.-C., Song, X.-F., Feng, L.-S., & Lv, Z.-S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.059 · Cited by 295
Oloya, B., Namukobe, J., Heydenreich, M., Ssengooba, W., Schmidt, B., & Byamukama, R. (2021) · Natural Product Communications · doi:10.1177/1934578x211035851 · Cited by 9
Metadata
- Authors
- Ollinger, J., Bailey, M. A., Moraski, G. C., Casey, A., Florio, S., Alling, T., Miller, M. J., & Parish, T.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-04
- Volume
- 8
- Issue
- 4
- Pages
- e60531
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2095318368
- Cited by
- 164
- References
- 3
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis. https://app.cochat.ai/papers/10.1371/journal.pone.0060531
- The paper
- Ollinger, J., Bailey, M. A., Moraski, G. C., Casey, A., Florio, S., Alling, T., Miller, M. J., & Parish, T. (2013). A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis. PLoS ONE. https://doi.org/10.1371/journal.pone.0060531
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.